logo image
search icon
Biopsy Devices Market

Biopsy Devices Market Size, Share & Trends Analysis Report By Product Type (Needle Biopsy Devices (Guidance Systems, Biopsy Consoles, Site Markers, Biopsy Guns (Automated Systems, Semi-Automated Systems), Needles), Skin Biopsy Devices (Punch Biopsy Instruments, Shave Biopsy Instruments), Consumables (Forceps, Trocars, Trays, Other Consumables), By Biopsy Type, By Anatomy, By Disease Type, By Guidance Technique, By Region, And By Segment Forecasts, 2023-2031.

Report ID : 2228 | Published : 2023-11-27 | Pages: 180 | Format: PDF/EXCEL

Biopsy Devices Market Size is valued at USD 6.03 Bn in 2022 and is predicted to reach USD 20.04 Bn by the year 2031 at a 14.39% CAGR during the forecast period for 2023-2031.

Biopsy Devices Market

A biopsy is a surgical procedure that takes tissue from an organ to detect the presence or extent of disease, most commonly malignant and inflammatory conditions. The most common people who carry it out are radiologists, surgeons, and interventional cardiologists. Biopsies are used to perform on any organ using specific biopsy instruments as a confirming test for cancer and celiac disease. The application of each biopsy equipment differs depending on the type of organ under consideration. The rising global cancer prevalence, untapped potential in emerging nations, particularly in Asia Pacific, and the improvement of healthcare infrastructure in these regions are among the important themes driving market growth.

However, the COVID-19 pandemic had a moderate impact on the market. Prioritizing cancer patients was difficult because healthcare personnel were mostly focused on COVID-19 patients. With a greater emphasis on avoiding viral infection, most people preferred fewer trips to healthcare settings. To some extent, this had a negative impact on the biopsy market. However, once the globe returned to normalcy and cancer cases increased, the market swiftly rebounded.

Competitive Landscape

Some Major Key Players In The Biopsy Devices Market:

  • Argon Medical Devices, Inc.
  • Braun SE
  • Becton
  • Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Conmed Corporation
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Inrad, Inc.
  • Medtronic plc
  • Olympus Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Zamar Care
  • Changzhou Jiuhong Medical Instrument Co., Ltd.
  • Kindly (KDL) Meditech
  • Ningbo Xinwell Medical Technology Co., LTD.
  • Shenzhen Manners Technology Co., Ltd.
  • Zhejiang Soudon Medical Technology Co., Ltd
  • Agilent Technologies, Inc.
  • BGI Group
  • Biocept, Inc.
  • Bio-Rad Laboratories, Inc.
  • Dxcover Limited
  • Elypta Limited
  • Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Micronoma
  • QIAGEN
  • Revvity, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc
  • Others

Market Segmentation:

The Biopsy Devices Market is segmented based on Product Type, Biopsy Type, Disease Type, Anatomy, and Guidance Technique. By Product Type segment comprises Needle Biopsy Devices (Guidance Systems, Biopsy Consoles, Site Markers, Biopsy Guns (Automated Systems, Semi-Automated Systems), Needles), Skin Biopsy Devices (Punch Biopsy Instruments, Shave Biopsy Instruments), and Consumables (Forceps, Trocars, Trays, Other Consumables). Whereas the Biopsy Type segment consists of Tissue Biopsy, which is again divided into Needle Biopsy, Surgical Biopsy and Skin Biopsy, and Liquid Biopsy. The Anatomy segment includes Breast, Lung, Bone, Liver, Uterus/Cervix/Ovary, Abdomen, Prostate, Cardiac, Skin, and Others. By Disease Type, the market is segmented into Cancer, Infections, Autoimmune Disorders, Non-Cancerous Indications, and Others. According to the Guidance Technique segment, the market is divided into Growth-Share Analysis, Ultrasound-Guided Biopsy, X-Ray-Guided Biopsy, MRI-Guided Biopsy, and CT-Guided Biopsy.

Based On The Offering, The Testing Service Segment Is Accounted As A Major Contributor In The Biopsy Devices Market. 

The Testing Service category is expected to hold a major share of the global Biopsy Devices Market in 2022. There are huge growth opportunities in this area as a result of rising public awareness and the increasing occurrence of malignancies and various non-oncology diseases. The incorporation of modern technologies such as next-generation sequencing (NGS) and molecular diagnostics improves the precision and accuracy of biopsy testing services, which leads to rising demand. The increased prevalence of cancer, autoimmune disorders, and infectious diseases creates a constant demand for biopsy testing services, as these problems frequently necessitate reliable diagnostic confirmation and surveillance.

The Treatment Monitoring Segment Witnessed Growth At A Rapid Rate.

The Treatment Monitoring segment is projected to grow rapidly in the global Biopsy Devices Market. The current domination of this category is mostly because of the availability of many cancer therapies monitoring liquid biopsies that key players now offer. Several variables impact the biopsy instruments market dynamic for treatment monitoring, including the developing landscape of cancer care, personalized medicine, and medical technology improvements.

In The Region, The North American Biopsy Devices Market Holds A Significant Revenue Share.

The North America Biopsy Devices Market is expected to record the maximum market share in revenue in the near future. Owing to the existence of established market players in the region, it is expected to continue to account for a sizable part of the market throughout the projection period. The regional market will likely benefit from high market penetration rates of technologically advanced equipment such as vacuum-assisted biopsy systems and rapidly expanding demand for disposable devices. Asia Pacific offers numerous prospects for market expansion. The rapid improvement of healthcare infrastructure in growing Asia Pacific countries, the prevalence of significant unmet patient demands, and the rising incidence of cancer are expected to drive regional market expansion.

Recent Developments:

  • In Sept 2023, A revolutionary collaboration has been declared between Roche France, Foundation Medicine, and the Institute Gustave Roussy to provide cancer patients in France with in-house liquid biopsy genomic testing. By transferring FoundationOne®Liquid CDx technology to the Institute Gustave Roussy, Roche France and Foundation Medicine have the potential to provide liquid biopsy testing for comprehensive genomic profiling (CGP) in all patients in France diagnosed with advanced cancer.
  • In August 2022, Mammotome announced the release of the Mammotome DualCoreTM biopsy system, the company's first twin-stage core biopsy tool. This novel core biopsy device adds to the Mammotome ultrasound-guided breast biopsy portfolio, which already includes the Mammotome® Elite Tetherless Vacuum-Assisted Biopsy Device (tetherless VABB) and the Mammotome RevolveTM Dual Vacuum-Assisted Breast Biopsy System (tethered VABB).

Biopsy Devices Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 6.03 Bn

Revenue Forecast In 2031

USD 20.04 Bn

Growth Rate CAGR

CAGR of 14.39% from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product Type, By Biopsy Type, By Anatomy, By Disease Type, By Guidance Technique 

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Argon Medical Devices, Inc., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Conmed Corporation, FUJIFILM Holdings Corporation, GE Healthcare, Inrad, Inc., Medtronic plc, Olympus Corporation, Siemens Healthineers AG, Stryker Corporation, Zamar Care, Changzhou Jiuhong Medical Instrument Co., Ltd., Kindly (KDL) Meditech, Ningbo Xinwell Medical Technology Co., LTD., Shenzhen Manners Technology Co., Ltd., Zhejiang Soudon Medical Technology Co., Ltd, Agilent Technologies, Inc., BGI Group, Biocept, Inc., Bio-Rad Laboratories, Inc., Dxcover Limited, Elypta Limited, F. Hoffmann-La Roche Ltd, Illumina, Inc., Micronoma, QIAGEN, Revvity, Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc.

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Biopsy Devices Market Snapshot

Chapter 4. Global Biopsy Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis

5.1. By Product, & Market Share, 2020 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Product:

5.2.1. Needle Biopsy Devices

5.2.1.1. Guidance Systems

5.2.1.2. Biopsy Consoles

5.2.1.3. Site Markers

5.2.1.4. Biopsy Guns

5.2.1.4.1. Automated Systems

5.2.1.4.2. Semi-Automated Systems

5.2.1.5. Needles

5.2.2. Skin Biopsy Devices

5.2.2.1. Punch Biopsy Instruments

5.2.2.2. Shave Biopsy Instruments

5.2.3. Consumables

5.2.3.1. Forceps

5.2.3.2. Trocars

5.2.3.3. Trays

5.2.3.4. Other Consumables

Chapter 6. Market Segmentation 2: By Biopsy Type Estimates & Trend Analysis

6.1. By Biopsy Type & Market Share, 2020 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Biopsy Type:

6.2.1. Tissue Biopsy

6.2.1.1. Needle Biopsy

6.2.1.2. Skin Biopsy

6.2.1.3. Surgical Biopsy

6.2.2. Liquid Biopsy

Chapter 7. Market Segmentation 3: By Disease Type Estimates & Trend Analysis

7.1. By Disease Type & Market Share, 2020 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Disease Type:

7.2.1. Cancer

7.2.2. Infections

7.2.3. Autoimmune Disorders

7.2.4. Non-Cancerous Indications

7.2.5. Others

Chapter 8. Market Segmentation 4: By Anatomy Estimates & Trend Analysis

8.1. By Anatomy & Market Share, 2020 & 2031

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Anatomy:

8.2.1. Breast

8.2.2. Lung

8.2.3. Bone

8.2.4. Liver

8.2.5. Uterus/Cervix/Ovary

8.2.6. Abdomen

8.2.7. Prostate

8.2.8. Cardiac

8.2.9. Skin

8.2.10. Others

Chapter 9. Market Segmentation 5: By Guidance Technique Estimates & Trend Analysis

9.1. By Guidance Technique & Market Share, 2020 & 2031

9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Guidance Technique:

9.2.1. X-Ray-Guided Biopsy

9.2.2. Ultrasound-Guided Biopsy

9.2.3. MRI-Guided Biopsy

9.2.4. CT-Guided Biopsy

Chapter 10. Biopsy Devices Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Product, 2019-2031

10.1.2. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Biopsy Type, 2019-2031

10.1.3. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Disease Type, 2019-2031

10.1.4. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Anatomy, 2019-2031

10.1.5. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Guidance Technique, 2019-2031

10.1.6. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

10.2. Europe

10.2.1. Europe Biopsy Devices Market revenue (US$ Million) By Product, 2019-2031

10.2.2. Europe Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2019-2031

10.2.3. Europe Biopsy Devices Market revenue (US$ Million) By Disease Type, 2019-2031

10.2.4. Europe Biopsy Devices Market revenue (US$ Million) By Anatomy, 2019-2031

10.2.5. Europe Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2019-2031

10.2.6. Europe Biopsy Devices Market revenue (US$ Million) by country, 2019-2031

10.3. Asia Pacific

10.3.1. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Product, 2019-2031

10.3.2. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2019-2031

10.3.3. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Disease Type, 2019-2031

10.3.4. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Anatomy, 2019-2031

10.3.5. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2019-2031

10.3.6. Asia Pacific Biopsy Devices Market revenue (US$ Million) by country, 2019-2031

10.4. Latin America

10.4.1. Latin America Biopsy Devices Market revenue (US$ Million) By Product, 2019-2031

10.4.2. Latin America Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2019-2031

10.4.3. Latin America Biopsy Devices Market revenue (US$ Million) By Disease Type, 2019-2031

10.4.4. Latin America Biopsy Devices Market revenue (US$ Million) By Anatomy, 2019-2031

10.4.5. Latin America Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2019-2031

10.4.6. Latin America Biopsy Devices Market revenue (US$ Million) by country, 2019-2031

10.5. Middle East & Africa

10.5.1. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Product, 2019-2031

10.5.2. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2019-2031

10.5.3. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Disease Type, 2019-2031

10.5.4. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Anatomy, 2019-2031

10.5.5. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2019-2031

10.5.6. Middle East & Africa Biopsy Devices Market revenue (US$ Million) by country, 2019-2031

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles

11.2.1. Argon Medical Devices, Inc.

11.2.2. B. Braun SE

11.2.3. Becton, Dickinson and Company

11.2.4. Boston Scientific Corporation

11.2.5. Cardinal Health, Inc.

11.2.6. Cook Group Incorporated

11.2.7. Conmed Corporation

11.2.8. FUJIFILM Holdings Corporation

11.2.9. GE Healthcare

11.2.10. Inrad, Inc.

11.2.11. Medtronic plc

11.2.12. Olympus Corporation

11.2.13. Siemens Healthineers AG

11.2.14. Stryker Corporation

11.2.15. Zamar Care

11.2.16. Changzhou Jiuhong Medical Instrument Co., Ltd.

11.2.17. Kindly (KDL) Meditech

11.2.18. Ningbo Xinwell Medical Technology Co., LTD.

11.2.19. Shenzhen Manners Technology Co., Ltd.

11.2.20. Zhejiang Soudon Medical Technology Co., Ltd

11.2.21. Agilent Technologies, Inc.

11.2.22. BGI Group

11.2.23. Biocept, Inc.

11.2.24. Bio-Rad Laboratories, Inc.

11.2.25. Dxcover Limited

11.2.26. Elypta Limited

11.2.27. F. Hoffmann-La Roche Ltd

11.2.28. Illumina, Inc.

11.2.29. Micronoma

11.2.30. QIAGEN

11.2.31. Revvity, Inc.

11.2.32. Sysmex Corporation

11.2.33. Thermo Fisher Scientific Inc.

Segmentation of Biopsy Devices Market-

Biopsy Devices Market By Product Type-

  • Needle Biopsy Devices
    • Guidance Systems
    • Biopsy Consoles
    • Site Markers
    • Biopsy Guns
      • Automated Systems
      • Semi-Automated Systems
    • Needles
  • Skin Biopsy Devices
    • Punch Biopsy Instruments
    • Shave Biopsy Instruments
  • Consumables
    • Forceps
    • Trocars
    • Trays
    • Other Consumables

Biopsy Devices Market Seg

Biopsy Devices Market By Biopsy Type

  • Tissue Biopsy
    • Needle Biopsy
    • Surgical Biopsy
    • Skin Biopsy
  • Liquid Biopsy

Biopsy Devices Market By Anatomy-

  • Breast
  • Lung
  • Bone
  • Liver
  • Uterus/Cervix/Ovary
  • Abdomen
  • Prostate
  • Cardiac
  • Skin
  • Others

Biopsy Devices Market By Disease Type-

  • Cancer
  • Infections
  • Autoimmune Disorders
  • Non-Cancerous Indications
  • Others

Biopsy Devices Market By Guidance Technique -

  • Growth-Share Analysis
  • Ultrasound-Guided Biopsy
  • X-Ray-Guided Biopsy
  • MRI-Guided Biopsy
  • CT-Guided Biopsy

Biopsy Devices Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Biopsy Devices Market?

Biopsy Devices Market expected to grow at a 14.39% CAGR during the forecast period for 2023-2031.

F. Hoffmann-La Roche Ltd, Illumina, Inc., Micronoma, QIAGEN, Revvity, Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach